Sotir Mark R 4

What Happened
Mark R. Sotir, Chair of the Board of Ardent Health, received a grant of 14,231 restricted stock units (transaction code A) on April 1, 2026. The grant is reported at a $0.00 per-share acquisition price (total $0 reported for the grant). This was an award/compensation grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-01; filing date: 2026-04-02 (appears timely).
• Grant: 14,231 restricted stock units reported at $0.00 per unit.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: RSUs vest in full on the first anniversary of April 1, 2026, subject to Sotir’s continued service through the vesting date.
• Transaction type: Award/Grant (code A). No 10b5-1 plan, tax-withholding, or late-filing indication provided.

Context
Restricted stock units are a form of compensation that convert into shares only upon vesting; they do not represent immediately tradable shares. Such grants are typically for compensation or retention and are not direct indicators of buy/sell sentiment. The reported $0.00 price reflects that this was an award rather than a market purchase.